Staphylococcal infection of the bronchial tree is so common in cystic fibrosis, in contrast to its much less frequent occurrence in other chronic disorders of the lower respiratory tract, that the view is now widely held that unusual susceptibility to bronchial infection by Staph. aureus is a characteristic feature of the condition. Indeed, some authorities believe that the initial lung damage in cystic fibrosis is always brought about by staphylococcal infection and that other respiratory pathogens such as H. influenzae, Ps. aeruginosa, and Kleb. pneumoniae can become established only in lungs already damaged in this way. As a corollary, Lawson (1969) believes that prevention of staphylococcal infection in patients with cystic fibrosis will prevent lung damage from occurring and will consequently preclude infection by other pathogens. He therefore prescribes continuous antistaphylococcal chemoprophylaxis for all his patients from the time of diagnosis of cystic fibrosis. Burns and May (1968) described the occurrence of bacterial precipitins in the serum of 30 patients aged 9 to 28 years with cystic fibrosis and concluded that their findings were in accord with the hypothesis outlined above. This series has now been extended to 195 patients, who form the subject of the present report. The findings, however, seem to be no longer compatible with the 'classical' hypothesis and suggest that children with cystic fibrosis are, in fact, abnormally susceptible to any respiratory pathogen from birth.
Material and Methods
Patients investigated. Serum samples were obtained from patients attending the cystic fibrosis clinics of Dr. J. C. Batten at Brompton Hospital, Dr. D. N.
Lawson at Queen Mary's Hospital, Carshalton, Dr. Margaret Meams at Queen Elizabeth Hospital, Hackney, and Dr. A. P. Norman at The Hospital for Sick Children, Great Ormond Street, London. The youngest patient was aged 3 weeks and the oldest 31 years at the time serum was examined. Sputum samples were also obtained from 96 of the patients aged 6 years or more. Though sputum may be expectorated by children younger than this, none of the 0-to 5-year-olds attended the Brompton Hospital and it was not practicable to obtain specimens from children in this age group.
Of the patients in this series, 102 were under the care of Dr. Margaret Meams and form the subject of an additional report in which bacteriological, clinical, and radiological findings are correlated (Meams, Hunt, and Rushworth, 1972) .
Immunological procedures. Double-diffusion precipitin tests were based on the method described by 908 Burns and May ( , 1968 and Burns (1968a, b) , modified as follows. Each serum was tested neat against antigen extracts of Staph. aureus (10 mg/ml), H. influenzae (20 mg/ml), Ps. aeruginosa (10 mg/ml), Strep. pneumoniae (2 mg/ml), and Kleb. pneumoniae (10 mg/ml). (Rawlins, 1953) .
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Results
In Table I are compared the overall prevalences of bacterial precipitins in the patients in this series and in those described by Burns and May (1968 precipitins in the serum and are hence thought to be pathogenic in chronic respiratory disease (Burns and May, 1968 Fig. 1 and 2 ). Even so, it is perhaps surprising that no patients with precipitins against both organisms were found in the 0-to 5-year group and there were only 3 out of a total of 28 patients with precipitins among the 6-to 10-year-olds. Secondly, the balance between infection by different bacterial species might have been distorted by the effect of antibacterial drugs. These might be expected to have reduced the prevalence of infection caused by staphylococci relative to those caused by pseudomonas, which are notoriously unresponsive to chemotherapy. For this effect to explain the discrepancy between the classical hypothesis and our observations, it is necessary to postulate that each of the 7 children with pseudomonas precipitins in the 0-to 5-year group had previously had infections with staphylococci which had been eradicated by the time we carried out our precipitin tests. Fig. 1 and 2 fairly represent the picture and, from our experience, limited to older patients, of antistaphylococcal therapy in cystic fibrosis, we do not think that this has significantly distorted the pattern of infections by different bacterial species. Thus, in patients over 10 years old eradication of staphylococci from the sputum with disappearance of precipitins from the serum is infrequently achieved. In fact we have seen it happen in only 10 of 47 patients studied in detail during the last 3 years. It does not follow that eradication of staphylococci from the respiratory tract of younger patients would be equally difficultindeed, assuming that many of the younger patients would have less lung damage than the ones we studied, it might be expected to be easier. However, the refractoriness of staphylococcal infections to treatment in older patients suggests that eradication of the organism is never likely to be simple, and the pattern of infection in the various age groups provides some support for this view. Thus, the observed incidence of staphylococcal infection increased more or less linearly with age ( Fig. 1 and 2 ), but it is unlikely that such a linear relation would have been found if the patients in the youngest age groups had responded significantly better to therapy than those in the older groups.
We believe, therefore, that contrary to the classical hypothesis children with cystic fibrosis are susceptible from birth to infection of the lower respiratory tract, not only by Staph. aureus, but also by other respiratory pathogens to which they may be exposed. It is pertinent to inquire how the classical hypothesis arose. Cystic fibrosis was first described by Andersen in 1938 and her finding of staphylococcal infection in the patients' lungs was confirmed by later reports (Farber, 1944; di Sant'Agnese and Andersen, 1946; di Sant'Agnese, 1956 aureus in the anterior nares, however, was regarded as a normal finding even in the days before chemotherapy (Wilson and Miles, 1964) , and it is not surprising that patients, who in reality may have been susceptible to both species, in fact became infected-only with staphylococci because it was more or less ubiquitous while pseudomonas was rare. Further, widespread recognition of the importance of H. influenzae in chronic respiratory disorders did not occur until the 1950's (Turk and May, 1967) , and in the light of the difficulties associated with the isolation of this organism from sputum (May, 1953) it is easy to envisage that its significance may have been overlooked in early studies of cystic fibrosis.
Looked at in another way, it is doubtful whether anyone with no preconceived ideas about the bacteriology of cystic fibrosis would conclude from the figures presented above that there was a special relation between Staph. aureus and cystic fibrosis; rather would he conclude that, though staphylococcal infection is undoubtedly more common than in other lower respiratory disorders, patients with this disease are abnormally susceptible ab initio to infection by any recognized pulmonary pathogens to which they are exposed. If this conclusion is correct, there are two important corollaries. First, as regards chemoprophylaxis, measures directed towards the prevention of staphylococcal infection only will not, we believe, prevent infection by other bacterial species. Prophylaxis should therefore be aimed at preventing infection by any species and, in the absence of a suitable agent for the discouragement of Ps. aeruginosa, uninfected patients should as far as possible be kept out of the hospital environment in order to minimize the risk of crossinfection by virulent strains. Secondly, studies of the nature of the susceptibility of the bronchi to infection in cystic fibrosis must take account not only of staphylococci but of other organisms as well. May and Roberts (1969) reported the preliminary findings of a study of the significance of p-hydroxyphenylacetic acid (p-HPAA) in susceptibility to staphylococcal infection. In the light of the findings of the present investigation, this study is being extended to include other species, and it has been found that Ps. aeruginosa, like Staph. aureus, is capable of utilizing p-HPAA. Details will be reported elsewhere.
Finally, two other features of the figures shown in Table I and Fig. 1 and 2 require comment. First, the occurrence of serum precipitins to pneumococci in the patients in this series was even lower than it was in those described by Burns and May (1968) , and the organism was isolated from the sputum of only one patient. It seems likely that the rarity of pneumococcal infection in cystic fibrosis is a byproduct of the antistaphylococcal therapy given to most patients. Secondly, in contrast to the rise in the prevalence of staphylococcal, haemophilus, and klebsiella infections, pseudomonas infections were found much less commonly in the oldest patients than in the 6-to 20-year-olds. This fall in prevalence might be explained by the failure of many patients with pseudomonas infections to survive into adult life, and the findings for the 11 patients in this series who are known to have died (Table II) lend support for this view. 8 of them had specific precipitins to Ps. aeruginosa in the serum while mucoid pseudomonas was found in the sputum of 8 of the 9 patients from whom cultures were made. It may well be, as Doggett and Harrison (1969) suggest, that infection with mucoid Ps. aeruginosa is currently one of the commonest causes of death of patients with cystic fibrosis, and the need to keep them out of hospital away from sources of crossinfection cannot be too strongly emphasized.
